PMID- 16510593 OWN - NLM STAT- MEDLINE DCOM- 20060418 LR - 20240104 IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 66 IP - 5 DP - 2006 Mar 1 TI - Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. PG - 2725-31 AB - A critical event in the pathogenesis of invasive and metastatic cancer is E-cadherin loss of function. Renal clear cell carcinoma (RCC) is characterized by loss of function of the von Hippel-Lindau tumor suppressor (VHL), which negatively regulates hypoxia-inducible factor-1 (HIF-1). Loss of E-cadherin expression and decreased cell-cell adhesion in VHL-null RCC4 cells were corrected by enforced expression of VHL, a dominant-negative HIF-1alpha mutant, or a short hairpin RNA directed against HIF-1alpha. In human RCC biopsies, expression of E-cadherin and HIF-1alpha was mutually exclusive. The expression of mRNAs encoding TCF3, ZFHX1A, and ZFHX1B, which repress E-cadherin gene transcription, was increased in VHL-null RCC4 cells in a HIF-1-dependent manner. Thus, HIF-1 contributes to the epithelial-mesenchymal transition in VHL-null RCC by indirect repression of E-cadherin. FAU - Krishnamachary, Balaji AU - Krishnamachary B AD - Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. FAU - Zagzag, David AU - Zagzag D FAU - Nagasawa, Hideko AU - Nagasawa H FAU - Rainey, Karin AU - Rainey K FAU - Okuyama, Hiroaki AU - Okuyama H FAU - Baek, Jin H AU - Baek JH FAU - Semenza, Gregg L AU - Semenza GL LA - eng GR - P50-CA103175/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (Basic Helix-Loop-Helix Transcription Factors) RN - 0 (Cadherins) RN - 0 (Homeodomain Proteins) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (RNA, Messenger) RN - 0 (RNA, Small Interfering) RN - 0 (Repressor Proteins) RN - 0 (TCF3 protein, human) RN - 0 (Transcription Factors) RN - 0 (ZEB1 protein, human) RN - 0 (ZEB2 protein, human) RN - 0 (Zinc Finger E-box Binding Homeobox 2) RN - 0 (Zinc Finger E-box-Binding Homeobox 1) RN - EC 2.3.2.27 (Von Hippel-Lindau Tumor Suppressor Protein) SB - IM MH - Basic Helix-Loop-Helix Transcription Factors/biosynthesis/genetics/*physiology MH - Biopsy MH - Cadherins/*biosynthesis/genetics MH - Carcinoma, Renal Cell/genetics/*metabolism/pathology MH - Cell Adhesion/physiology MH - Down-Regulation MH - Epithelial Cells/pathology MH - Gene Expression Regulation, Neoplastic MH - Homeodomain Proteins/biosynthesis/genetics/*physiology MH - Humans MH - Hypoxia-Inducible Factor 1/biosynthesis/genetics/*physiology MH - Immunohistochemistry MH - Kidney Neoplasms/genetics/*metabolism/pathology MH - Mesoderm/pathology MH - RNA, Messenger/biosynthesis/genetics MH - RNA, Small Interfering/genetics MH - Repressor Proteins/biosynthesis/genetics/*physiology MH - Transcription Factors/biosynthesis/genetics/*physiology MH - Transcription, Genetic MH - Von Hippel-Lindau Tumor Suppressor Protein/biosynthesis/genetics/*physiology MH - Zinc Finger E-box Binding Homeobox 2 MH - Zinc Finger E-box-Binding Homeobox 1 EDAT- 2006/03/03 09:00 MHDA- 2006/04/19 09:00 CRDT- 2006/03/03 09:00 PHST- 2006/03/03 09:00 [pubmed] PHST- 2006/04/19 09:00 [medline] PHST- 2006/03/03 09:00 [entrez] AID - 66/5/2725 [pii] AID - 10.1158/0008-5472.CAN-05-3719 [doi] PST - ppublish SO - Cancer Res. 2006 Mar 1;66(5):2725-31. doi: 10.1158/0008-5472.CAN-05-3719.